ALLERGAN has announced the registration in Australia of the first injectable gel implant, XEN Gel Implant, for leading global cause of irreversible blindness, glaucoma.
Pharmacists are encouraged to watch for patients struggling with multiple glaucoma eye drops to urge their return to their clinician to consider this new option which has led to around half of patients being free of drops within 12 months in some groups.
Visit glaucoma.org.au for more.
The above article was sent to subscribers in Pharmacy Daily's issue from 16 Aug 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 16 Aug 18
